News Daily News Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk Caitlin E. Cox February 13, 2026
News Daily News Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say L.A. McKeown July 22, 2025
News Daily News CVD Hospitalization in Older Adults Higher in US Than in Denmark Michael O'Riordan February 07, 2025
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Daily News ‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health L.A. McKeown July 04, 2022
News Daily News Poor Prepregnancy Cardiometabolic Health Observed Across the US Yael L. Maxwell February 14, 2022
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News ACC 2021 Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients Caitlin E. Cox May 07, 2021
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Industry News Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments January 03, 2016